Stay updated on Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Version 34 updates the record by renaming the study to include Placebo With ADT and adding the Contacts/Locations, Study Design, Study Status, and Study Identification sections. These changes align the study's identification with the protocol and provide essential administrative details for tracking.
    Difference
    0.5%
    Check dated 2026-02-18T16:33:53.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history. Removed the government funding lapse notice and operating-status guidance that previously appeared on the page.
    Difference
    0.5%
    Check dated 2026-02-11T11:36:06.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and the NIH Clinical Center's status. Updated the page revision to v3.4.1, with the previous revision v3.4.0 removed.
    Difference
    0.5%
    Check dated 2026-02-04T10:21:47.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now shows a Show glossary option and a legend for color-coded changes (green for additions, red for deletions). It also introduces the latest revision label (Revision: v3.4.0) and a minor capitalization change in 'No FEAR Act Data'.
    Difference
    0.7%
    Check dated 2026-01-28T06:15:35.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The history now shows Revision: v3.3.4 and omits Revision: v3.3.3, which affects only revision history metadata and does not alter the study's core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:48:29.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    New history entries were added for Contacts/Locations, Study Design, and Study Status, along with a new version (32) and Revision: v3.3.3; the entry for HHS Vulnerability Disclosure was removed.
    Difference
    0.6%
    Check dated 2025-12-23T20:37:05.000Z thumbnail image

Stay in the know with updates to Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.